Medherant

Medherant is a spinout from the University of Warwick. It is a clinical-stage company developing innovative transdermal drug delivery patches using its proprietary TEPI Patch® technology. This technology enables the delivery of higher drug doses through the skin, offering greater convenience and comfort for patients. Medherant focuses on treatments for women's health, pain management, and central nervous system diseases.